-The Economic Times The BT cotton revolution, which swept India's countryside, is now doubling up as the source of the country's cheapest cooking oil. And in Narendra Modi's motherland, the Jasubens are loving it. Cottonseed or 'kapasiya' oil is ruling in the kitchens of Gujarat, the largest cotton-growing state. One out of every two bottles of oil consumed in Gujarat contains cottonseed oil. "Earlier, we used around three litres of cottonseed oil...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...

-The Economic Times NEW DELHI: India Inc has been conspicuously absent from a four-year-old United Nations-led global initiative against corruption, an unflattering distinction for Indian industry that could also buttress a widespread feeling that doing business in the country is difficult without bribing officials. Not one Indian company has yet joined a global panel of companies steered by the world body to act against corruption in their businesses and pressurise governments...

-The Hindu THIRUVANANTHAPURAM: Dengue, the world's most rapidly spreading mosquito-borne viral disease, is taking a far bigger human toll than was believed to be the case. As many as 390 million people across the globe could be falling victim to the virus each year, according to a multinational study published by Nature on Sunday. India emerges in the analysis as the country with the world's highest dengue burden, with about 34 per...

-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor   The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...